Loss of alpha3(IV) collagen expression associated with corneal keratocyte activation

Emily Guerriero1, Jian Chen, Yoshikazu Sado

  • 1UPMC Eye Center, Ophthalmology and Visual Science Research Center, Eye and Ear Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

Abstract

Insights

The expression of alpha3(IV) collagen is lost when corneal stromal cells activate. This change, induced by growth factors like TGF-beta1, is a key marker of cell activation in the cornea.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Corneal stromal cells, known as keratocytes, maintain the cornea's transparency and structure.
  • Cellular activation in the corneal stroma is associated with wound healing and disease, involving phenotypic changes.
  • Type IV collagen isoforms are crucial components of basement membranes, but their specific roles in corneal stromal cell activation are not fully understood.

Purpose of the Study:

  • To investigate the association between the expression of type IV alpha1, alpha2, and alpha3 collagen isoforms and the activation state of corneal stromal cells.
  • To determine if specific growth factors induce changes in these collagen isoforms during cell activation.

Main Methods:

  • Keratocytes were isolated from rabbit corneal stroma and cultured in various media conditions, including serum-free, insulin, bFGF/heparin sulfate (HS), TGF-beta1, and fetal bovine serum (FBS).
  • Expression of type IV collagen isoforms and keratan sulfate proteoglycans (KSPGs) was assessed using immunocytochemistry and Western blot analysis.
  • Messenger RNA (mRNA) levels were quantified using SYBR Green RT-PCR.

Main Results:

  • Type IV alpha1, alpha2, and alpha3 collagens were detected in normal corneal stroma and quiescent keratocytes.
  • alpha3(IV) collagen expression and mRNA levels were significantly reduced in activated keratocytes cultured with FBS, bFGF/HS, or TGF-beta1, and in regenerating stroma post-PRK.
  • Keratan sulfate proteoglycans (lumican and keratocan) were expressed in quiescent cells, with insulin promoting their expression, while TGF-beta1 and FBS downregulated their mRNA levels.

Conclusions:

  • Loss of alpha3(IV) collagen expression is a specific marker for corneal stromal cell activation, both in vivo and in vitro.
  • Transforming growth factor-beta1 (TGF-beta1) and bFGF/HS are key inducers of this alpha3(IV) collagen downregulation.
  • This phenotypic shift is accompanied by altered expression of keratan sulfate proteoglycans, such as keratocan.